摘要
As our understanding of the mechanisms of cancer treatment has increased, a growing number of studies demonstrate pathways through which DNA damage repair (DDR) affects the immune system. At the same time, the varied response of patients to immune checkpoint blockade (ICB) therapy has prompted the discovery of various predictive biomarkers and the study of combination therapy. Here, our investigation explores the interactions involved in combination therapy, accompanied by a review that summarizes currently identified and promising predictors of response to immune checkpoint inhibitors (ICIs) that are useful for classifying oncology patients. In addition, this work, which discusses immunogenicity and several components of the tumor immune microenvironment, serves to illustrate the mechanism by which higher response rates and improved efficacy of DDR inhibitors (DDRi) in combination with ICIs are achieved.
学科与关键词
- New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review)Wang, Yanjun; Yang, Shuo; Wan, Li; Ling, Wei; Chen, Hao*; Wang, Jinghua*International Journal of Oncology, 2023, 63(1): 86.被引 3
- A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancerDing, Ke; He, Youhua; Wei, Jinfen; Fu, Shuying; Wang, Jiajian; Chen, Zixi; Zhang, Haibo; Qu, Yimo; Liang, Keying; Gong, Xiaocheng; Qiu, Li; Chen, Dong; Xiao, Botao*; Du, Hongli*Frontiers in Immunology, 2022, 13: 943090.被引 3
- Biomarkers related to immune checkpoint inhibitors therapyLi, Na; Hou, Xin; Huang, Shaogang; Tai, Risheng; Lei, Lei; Li, Siyu; Abuliz, Adina; Wang, Geng*; Yang, Shanru*Biomedicine and Pharmacotherapy, 2022, 147: 112470.被引 9
